Announcement of Resolutions of the 8th Meeting of the Second Board of Directors of Guobang Pharmaceutical
Management Measures for the First Phase of Country Union Pharmacy Employee Stock Ownership Plan.
Independent financial advisor report on the first employee stock ownership plan (draft) of Guobang Pharmaceutical Group Co., Ltd. from Rongzheng Enterprise Consulting Services (Group) Co., Ltd. Shanghai.
Legal Opinion of Guohao Law Firm (Hangzhou) on the First Phase Employee Stock Ownership Plan of Guobang Pharmaceutical Group Co., Ltd.
Verification opinion on the first phase of the company's employee shareholding plan by Guobang Pharmaceutical's supervisors.
Announcement of the resolution of the 7th meeting of the 2nd Board of Supervisors of Guobang Pharmaceutical
Special Legal Opinion of Guohao Law Firm (Hangzhou) on the Differential Dividend of Guobang Medicine
Verification opinions of Guotai Junan Securities Co., Ltd. on the completion of Guobang Pharmaceutical Group Co., Ltd.\'s fund-raising project and permanently replenish working capital with savings raised
Guobang Pharmaceutical\'s announcement on the estimated amount of guarantee provided to subsidiaries in 2024
Guobang Pharmaceutical\'s Feasibility Analysis Report on Launching Foreign Exchange Hedging Business
Guobang Pharmaceutical\'s announcement on changes in accounting policies
Lixin Certified Public Accountants on Guobang Pharmaceutical\'s 2023 Audit Report and Financial Statement
Announcement of Resolutions of the 6th Meeting of the 2nd Board of Supervisors of Guobang Pharmaceutical
Guobang Pharmaceutical 2023 Environmental, Social and Corporate Governance (ESG) Report
Lixin Certified Public Accountants Certified Public Accountants Special Report on the Annual Storage and Use of Funds Raised by Guobang Pharmaceutical in 2023
Guobang Pharmaceutical's announcement on renewing the appointment of an auditor
Guobang Pharmaceutical\'s special report on the storage and use of funds raised in 2023
Guobang Pharmaceutical\'s announcement on the completion of the fund-raising project and permanently supplementing working capital with the savings raised
Lixin Certified Public Accountants Limited\'s special audit report on Guobang Pharmaceutical\'s 2023 non-operating capital occupation and other related capital transactions
Lixin Certified Public Accountants on Guobang Pharmaceutical\'s 2023 Internal Control Audit Report
No Data